Trials / Conditions / Indeterminate Colitis

Indeterminate Colitis

20 registered clinical trials studyying Indeterminate Colitis — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Zymfentra (Infliximab-dyyb) REal World Cohort STudy NCT07237516	University of North Carolina, Chapel Hill	—
Recruiting	Evaluation of the SMART IBD App in Pediatric IBD NCT07195123	Children's Hospital Medical Center, Cincinnati	N/A
Recruiting	Family Members At INcreased-risk for Developing Inflammatory Bowel Disease NCT06655415	Massachusetts General Hospital	—
Recruiting	Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE) NCT06315179	Seattle Children's Hospital	—
Unknown	Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD NCT05663671	Meharry Medical College	—
Completed	High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD) NCT05587673	Stanford University	Phase 1
Recruiting	Digestive Biobank for Exploring Microbiota-host Interactions NCT05704413	Assistance Publique - Hôpitaux de Paris	—
Completed	Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients NCT04672161	Weill Medical College of Cornell University	N/A
Unknown	TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate Pa NCT04031482	Ced Service GmbH	—
Completed	High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-st NCT04191655	Beth Israel Deaconess Medical Center	N/A
Recruiting	CEDUR - German IBD Registry NCT07319442	ImmunoRegister gUG	—
Completed	Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease NCT03301311	Children's Hospital Medical Center, Cincinnati	N/A
Active Not Recruiting	A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease NCT03251118	Target PharmaSolutions, Inc.	—
Completed	Fecal Calprotectin Collection Protocol NCT03143517	DiaSorin Inc.	—
Unknown	Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease NCT02066272	Maria Sklodowska-Curie National Research Institute of Oncology	—
Completed	Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis NCT03268213	Stony Brook University	EARLY_Phase 1
Completed	Self-Management Assistance for Recommended Treatment (SMART) Portal NCT01966744	Children's Hospital Medical Center, Cincinnati	—
Completed	Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD) NCT01692743	University of Maryland, Baltimore	Phase 3
Completed	Improving Medication Adherence in Pediatric Inflammatory Bowel Disease NCT01536509	Children's Hospital Medical Center, Cincinnati	N/A
Active Not Recruiting	A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Di NCT00606346	Janssen Biotech, Inc.	—